| Prev Close | 6.52 |
| Open | 6.58 |
| Day Low/High | 6.44 / 6.63 |
| 52 Wk Low/High | 5.13 / 9.20 |
| Volume | 94.32K |
| Avg Volume | 258.20K |
RedHill Biopharma Ltd. (RDHL)
6.58
0.06
0.92
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 35.27M |
| Market Cap | 228.92M |
| EPS | -1.70 |
| P/E Ratio | 38.35 |
| Div & Yield | N.A. (N.A) |
Latest News
How I Invest In Biotech Stocks
Here's two 'rules of the road' when investing in this highly volatile space.
Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers
The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.
3 Small Biotechs That Still Have Upside
Companies developing drugs for cancer, eye problems and pets -- offer untapped value.
One Small Pharma Stock Has Big Potential
Redhill has some promising drugs in its pipeline, and is well funded.
5 Small-Cap Biotechs With Big Potential
These 5 stocks all have positive catalysts on the horizon.
5 Small-Cap Biotechs With Big Potential
These 5 stocks all have positive catalysts on the horizon.
